ArticleEuropean journal of medical research2025
Squamous cell carcinoma antigen levels in women with cervical cancer and those without cervical cancer: a cross-sectional study among women of African descent.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development and External Validation of an Interpretable Machine Learning Model Using Routine Blood Biomarkers for Differentiating Malignant Breast Nodules.Journal of inflammation research · 2026Article
- A warning to young women: a case of giant ovarian mature cystic teratoma with squamous cell carcinoma transformation in a 22-year-old female and analysis of its molecular features.American journal of cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGlobally, cervical cancer is one of the most common cancers among females with 604,000 new cases and 342,000 deaths annually. It is a disease of public health importance. Detection of a tumour-specific antigen may be useful in the detection and early management of the disease. The squamous cell carcinoma antigen, a glycoprotein produced in squamous epithelial cells, could serve as a tumour marker in the diagnosis and management of cervical cancer. The aim of this study was to compare the serum levels of squamous cell carcinoma antigen in women with cervical cancer with normal non-cancerous controls and to identify its clinical and sociodemographic correlates.
methodsThis was a comparative cross-sectional study between women with histologically confirmed squamous cell carcinoma of the cervix and women without cervical cancer at the University of Benin Teaching Hospital in Nigeria. Eighty women were recruited for the study, which consisted of 40 cases of cervical cancer and a comparative group of 40 women without cervical cancer. Levels of squamous cell carcinoma antigen were determined by enzyme-linked immunosorbent assay (ELISA). Data were analysed using the Statistical Package for Social Sciences (SPSS) for Windows, version 27.
resultsThere was a statistically significant difference in the mean squamous cell carcinoma antigen levels in women with cervical cancer (0.7 ± 0.5 ng/ml) and those without cervical cancer (0.4 ± 0.2 ng/ml) (p = 0.0003). Using a cut-off value of 0.45, the sensitivity of SCCA was 75% while specificity was 70%. Its positive predictive value was71.4% while the negative predictive value was 73.7%. The stage of disease, parametrial involvement, metastasis, body mass index, age, parity, alcohol consumption and menopausal status did not significantly affect levels of the tumour marker.
conclusionThe serum levels of squamous cell carcinoma antigen are elevated in Nigerian women with cervical cancer compared to those without cervical cancer. Sociodemographic factors and extent of disease do not appear to significantly affect levels of the tumour marker.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.